Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.

@article{Falandry2013DevelopmentOA,
  title={Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.},
  author={Claire Falandry and B{\'e}atrice Weber and A Savoye and Fabien Tinquaut and Olivier Tr{\'e}dan and Emmanuel Sevin and Laetitia St{\'e}fani and Francesco Savinelli and Mustapha Atlassi and Jacques Salvat and {\'E}ric Pujade-Lauraine and Gilles Freyer},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2013},
  volume={24 11},
  pages={2808-13}
}
BACKGROUND Two previous GINECO elderly specific studies in advanced ovarian cancer (AOC) patients highlighted the prognostic value of geriatric covariates for overall survival (OS). PATIENTS AND METHODS This open-label prospective trial was designed to identify the impact of geriatric covariates on OS in AOC patients ≥70 years treated with first-line carboplatin. RESULTS Geriatric covariates of the 111 patients included median age 79 years (≥80 years: 41%); performance status (PS) ≥2: 47… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
15 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Carboplatin cyclophosphamide or carboplatin pacitaxel in elderly with advanced ovarian cancer? Analysis of two consecutive trials from the GINECO

  • O Trédan, JF Geay, S Touzet
  • Ann Oncol
  • 2007
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…